Mereo BioPharma Group
MREO
#6472
Rank
NZ$0.98 B
Marketcap
$6.35
Share price
1.09%
Change (1 day)
79.45%
Change (1 year)

Revenue for Mereo BioPharma Group (MREO)

Revenue in 2024 (TTM): NZ$14.83 Million

According to Mereo BioPharma Group's latest financial reports the company's current revenue (TTM ) is NZ$15.35 Million. In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of NZ$83.98 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mereo BioPharma Group from 2016 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$14.83 M
2022N/A-100%
2021NZ$83.98 M
2020N/A
2019N/A
2018N/A
2017N/A
2016N/A